Wikidata

(Q39518245)

English

Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease

scientific article published on 17 June 2011

In more languages

Statements

title
Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21704161
retrieved
12 September 2017
author name string
Raymond T Bartus
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
21704161
retrieved
12 September 2017
Lamar Brown
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
21704161
retrieved
12 September 2017
Alistair Wilson
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
21704161
retrieved
12 September 2017
Brian Kruegel
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
21704161
retrieved
12 September 2017
Joao Siffert
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
21704161
retrieved
12 September 2017
Eugene M Johnson
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
21704161
retrieved
12 September 2017
Christopher D Herzog
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
21704161
retrieved
12 September 2017
publication date
17 June 2011
1 reference
stated in
Europe PubMed Central
PubMed ID
21704161
retrieved
12 September 2017
page(s)
38-52
1 reference
stated in
Europe PubMed Central
PubMed ID
21704161
retrieved
12 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39518245&oldid=1833906236"